@DocRirie @OceAlaB https://t.co/zYKsSdMLqR biais de publication majeur.
“ The effect in DLB remains unclear. ” / “Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's dis…” https://t.co/fSP5ef1yEe
Cholinesterase inhibitors are beneficial for people with Parkinson's disease and dementia | Cochrane https://t.co/l8n2cRJlZB
@p_gral0 @Dr_Stephane @qffwffq Débat qui sent toujours le soufre mais il y a pourtant des arguments pour une petite utilité dans la démence park https://t.co/LuDPhV1K6o
RT @DrADKline: Risky from $AXON. Would like to have been in that internal meeting: https://t.co/ubhRc5yuLw, https://t.co/cBf0bX6V7e https:/…
Revisión Cochrane sobre beneficio inhibidores acetilcolinesterasa en Demencia asociada a #Parkinson http://t.co/hqOwFZZ8
Revisión Cochrane sobre beneficio inhibidores acetilcolinesterasa en Demencia asociada a #Parkinson http://t.co/hqOwFZZ8
Revisión Cochrane sobre beneficio inhibidores acetilcolinesterasa en Demencia asociada a #Parkinson http://t.co/hqOwFZZ8
AlzheimersMed: Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive i... http://t.co/gLoe7WBh
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment i... http://t.co/KpieUapQ